SAKURA SEIKI Co., Ltd.-Corporate Profile-President's Message

Home › Corporate Profile › President's Message

Michio Hayashi,
Representative Director & President

Foreword

Inaugurated as a pioneer of the medical equipment industry in Japan, the birth of Sakura dates back to 1871 - soon after the Meiji Restoration. For the ensuing 140 or so years, Sakura has contributed to the development of Japan's healthcare industry, getting through numerous challenges and hardships. Several important transitions in its business content include separation of manufacture and sales divisions some 90 years ago. In 2006, the company re-integrated manufacture and sales divisions to become the new Sakura as we see today, in order to respond promptly to fast occurring changes in the market. Ancestors of Sakura's founding family were druggists, whose origin dates back close to the opening of the government of Edo by the Shogun Tokugawa Ieyasu in 1603. While having little intention to show off Sakura's long history, the painstaking endeavors and great achievements of our predecessors capture us with great astonishment. Indeed, we cannot help taking the old saying “Continuation Is Strength” to heart.

Future goals of Sakura

Keeping ourselves in tune with trends in the market fronts, Sakura wishes to be a well-established, reliable manufacturer that contributes to the market, our customers and society by constantly delivering trustworthy and valuable products, services and systems including software packages.
Sakura's primary business lines are largely classified into:

Infection control related business as introducing washer and sterilizer in particular.
Lab equipment business in pathology, cytology and immunology.

Both the former and the latter are extremely meaningful and significant operations for the benefit of healthcare forefronts and society. Given that the world economy, full recovery is still far in the wake of the Lehman Shock, except China and a few emerging countries. Since the conventional business cycle theory is no longer expected to exert a favorable effect on the economy, creating a highly dynamic business model which allows positively respond to structural changes in the world economy, is essential. Taking a bold yet cautious approach, Sakura will build up an ingenious, solid system for our sustainable growth.

Toward further globalization

When it comes to Sakura's laboratory related equipment business, we are energetically promoting globalization in collaboration with Sakura Group companies and have overpowered the competition, successfully achieving the top share of the world market. We will maintain and expand this position in years to come.
Sakura's infection control related equipment business has been more domestic- demand-led. Having seen the arrival of a turning point, we are now urged to seek business opportunities in overseas markets, while looking after the domestic market solidified by our strength as the top manufacturer in Japan. Sakura will be committed that the sales proportion between the domestic market and the overseas market is 50/50 for the time being, and the manufacture of the products will be coming along in future.

Conclusion

Sakura continues to strive for the benefit of healthcare and society with a clear future vision, as remaining in tune with the times.

Michio Hayashi, Representative Director & President
Sakura Seiki Co., Ltd.